Trial intelligence / Profile preview

Remimazolam vs Propofol for General Anesthesia in Elective Surgery

NCT03669484Phase 3Completed

Sponsor
R-Pharm
Start
Aug 2017
Primary completion
May 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of remimazolam, sponsored by R-Pharm. Started Aug 2017; status: completed.

02

Drugs

remimazolam

Beyond the preview

Go deeper on NCT03669484.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03669484.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call